PROVIA
Live / Allowed — Approved for publication (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99575283
- Mark type
- Stylized text
- Filed
- 02 Jan 2026
- Attorney of record
- Marcy L. Sperry
Goods and services
- Class 005 — Pharmaceuticals: Human biological amniotic membrane tissue intended for subsequent implantation; biologic drugs for treating inflammation and pain using regenerative tissue components; topical treatment in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of a micronized powder comprising amniotic material for medical purposes; wound treatment in the nature of a dressing comprising amniotic material; allograft made from amniotic material
Owner
- MiMedx Group, Inc., Marietta, GA, US
Prosecution history
- 09 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 May 2026 — NON-FINAL ACTION E-MAILED
- 28 May 2026 — NON-FINAL ACTION WRITTEN
- 01 May 2026 — ASSIGNED TO EXAMINER
- 02 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 02 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Jan 2026 — NEW APPLICATION ENTERED